We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-8.09%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$176M
AUM Growth
-$66.3M
Cap. Flow
-$43.6M
Cap. Flow %
-24.78%
Top 10 Hldgs %
39.96%
Holding
51
New
2
Increased
12
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.98M
2
A icon
Agilent Technologies
A
+$3.69M
3
LLY icon
Eli Lilly
LLY
+$3.45M
4
SYK icon
Stryker
SYK
+$2.47M
5
NVO
Novo Nordisk
NVO
+$1.66M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$7.51M
2
CVS icon
CVS Health
CVS
+$6.07M
3
LH icon
Labcorp
LH
+$5.27M
4
GMED icon
Globus Medical
GMED
+$4.8M
5
CYH icon
Community Health Systems
CYH
+$3.56M

Sector Composition

Rank Sector Weight
1 Healthcare 96.12%
2 Energy 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
26
Tenet Healthcare
THC
$21.1B
$3.68M 2.09%
70,000
-20,000
-22% -$1.39M
EHC icon
27
Encompass Health
EHC
$12.2B
$3.64M 2.07%
81,705
-21,862
-21% -$1.12M
MDT icon
28
Medtronic
MDT
$114B
$3.59M 2.04%
40,000
+5,000
+14% +$507K
A icon
29
Agilent Technologies
A
$42B
$3.56M 2.02%
+30,000
New +$3.69M
CRL icon
30
Charles River Laboratories
CRL
$13.6B
$3.21M 1.82%
15,000
-5,000
-25% -$1.22M
LHCG
31
DELISTED
LHC Group LLC
LHCG
$3.12M 1.77%
20,000
– –
AVTR icon
32
Avantor
AVTR
$9.23B
$3.11M 1.77%
100,000
-80,000
-44% -$2.5M
OPCH icon
33
Option Care Health
OPCH
$3.55B
$2.78M 1.58%
100,000
-30,000
-23% -$854K
SGRY icon
34
Surgery Partners
SGRY
$1.95B
$2.17M 1.23%
75,100
+18,080
+32% +$790K
SEM
35
DELISTED
Select Medical
SEM
$2.13M 1.21%
167,040
-74,240
-31% -$953K
CAH icon
36
Cardinal Health
CAH
$55.1B
$2.09M 1.19%
40,000
– –
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
$1.77M 1.01%
10,000
-7,500
-43% -$1.08M
GRFS
38
Grifois
GRFS
$5.39B
$1.19M 0.68%
100,000
-100,000
-50% -$1.19M
ABBV icon
39
AbbVie
ABBV
$440B
– –
-20,000
Closed -$3.24M
AMED
40
DELISTED
Amedisys
AMED
– –
-20,000
Closed -$3.45M
BNTX icon
41
BioNTech
BNTX
$23.3B
– –
-10,000
Closed -$1.71M
CVS icon
42
CVS Health
CVS
$120B
– –
-60,000
Closed -$6.07M
CYH icon
43
Community Health Systems
CYH
$406M
– –
-300,000
Closed -$3.56M
GH icon
44
Guardant Health
GH
$22.2B
– –
-40,000
Closed -$2.65M
GMED icon
45
Globus Medical
GMED
$11.2B
– –
-65,000
Closed -$4.8M
INCY icon
46
Incyte
INCY
$24.4B
– –
-35,000
Closed -$2.78M
LH icon
47
Labcorp
LH
$25.9B
– –
-23,280
Closed -$5.27M
MRNA icon
48
Moderna
MRNA
$24.6B
– –
-10,000
Closed -$1.72M
NBIX icon
49
Neurocrine Biosciences
NBIX
$16.1B
– –
-22,500
Closed -$2.11M
NTRA icon
50
Natera
NTRA
$45.5B
– –
-50,000
Closed -$2.03M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q2 2022 Portfolio in Review

As of Q2 2022, Sivik Global Healthcare held 51 positions worth $176M, down 27% from $242M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sivik Global Healthcare withdrew a net $43.6M in Q2 2022, closing 13 positions and reducing 17 holdings. Its most notable exit was CVS Health, an estimated $6.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 93% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Sanofi worth $3.75M.

  • Sivik Global Healthcare's largest Q2 2022 buy was Sanofi: 75,000 shares worth $3.75M.
  • Sivik Global Healthcare added most to Eli Lilly in Q2 2022, an estimated $3.45M increase.
  • Sivik Global Healthcare's biggest Q2 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $7.51M.
  • Sivik Global Healthcare fully exited CVS Health in Q2 2022, selling an estimated $6.07M.
  • Sivik Global Healthcare's ten largest holdings make up 40% of its $176M portfolio in Q2 2022.
  • Sivik Global Healthcare opened 2 new positions and closed 13 in Q2 2022.
  • Sivik Global Healthcare's portfolio value fell 27% quarter-over-quarter to $176M.

Based on Sivik Global Healthcare's 13F filing for Q2 2022, filed 10 Aug 2022.